The imperative to develop a human vaccine for the Hendra virus in Australia

• Main Authors: Bilal A. Zahoor, Lucy I. Mudie
• Format: Article
• Language: English
• Published: Taylor & Francis Group 2015-10-01
• Series: Infection Ecology & Epidemiology
• Subjects: Australia; Hendra; Henipavirus; bats; zoonotic Infections
• Online Access: http://www.infectionecologyandepidemiology.net/index.php/iee/article/view/29619/pdf_28

The Hendra virus (HeV) poses a significant challenge to public health in Australia. Expanding migratory patterns observed among bats and the mutation of the virus to seek and successfully infect new hosts is a significant departure from the generalized epidemiological trend. The recent discovery of equine-related infections and deaths in addition to a canine infection demonstrates the inadequacy of the current equine vaccine developed in 2012. Traditional models for controlling the spread of the vector are futile given the rapid pace at which bats' habitats are eroded. Recent ongoing zoonotic epidemics, for example, Ebola and Middle East respiratory syndrome coronavirus, demonstrate that human-to-human transmission is a distinct reality rather than an obscure possibility. The development of a human HeV vaccine is essential for the biosecurity of Australia, as part of a multipronged strategy to control HeV in Australia.